newsfilter
← Latest News
GlobeNewswire·

Revive Therapeutics to Investigate Bucillamine's Potential in Cancer Treatment

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF) (CSE:RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of